3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and their use in the treatment of i karos family zinc finger 2 (IKZF2)-dependent diseases

A C1-C6, -NH2 technology, applied in the direction of medical preparations containing active ingredients, drug combinations, organic active ingredients, etc., can solve problems such as excessive toxicity, difficulty in heterodimerization, and limited therapeutic utility

Pending Publication Date: 2021-02-05
NOVARTIS AG
View PDF398 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The fifth Ikaros family protein, Pegasus (IKZF5), shares only 25% identity with IKZF2, binds to a different DNA site than other Ikaros family members, and does not readily heterodi

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0524]Example 1: A compound of formula (I'), wherein:

[0525]X1And X2Each independently is H, (C1-C4)Alkyl, (C1-C6)Alkoxy, (C1-C4) Haloalkyl,

[0526](C1-C6)Haloalkoxy, (C3-C7) Cycloalkyl, halogen, CN, -OH, or -NH2;

[0527]RxIs H or D;

[0528]Each RaAnd RbIndependently H or D, or RaAnd RbTogether with the atoms to which they are attached, form = (O);

[0529]R1Yes

[0530]R2Is H, (C1-C6)Alkyl, (C1-C6)Haloalkyl, or (C3-C6) Cycloalkyl; or

[0531]R2And R7Together with the nitrogen atom to which they are attached to form a 6-membered or 7-membered heterocycloalkyl ring;

[0532]Each R3It is independently (C1-C6)Alkyl, (C1-C6)Alkoxy, (C1-C6)Haloalkyl, (C1-C6) Haloalkoxy, halogen, CN, -OH, or -NH2;or

[0533]Two R3Together with the carbon atoms to which they are attached (C3-C7) Cycloalkyl or 4- to 7-membered heterocycloalkyl ring, the heterocycloalkyl ring containing 1-3 heteroatoms selected from O, N and S; or when two R3When on adjacent carbon atoms together form a phenyl group, or a 5- or 6-membered heteroaryl

Example Embodiment

[0554]Embodiment 2: The compound as described in embodiment 1, which has formula (I), wherein:

[0555]RxIs H or D;

[0556]R1Yes

[0557]R2Is H, (C1-C6)Alkyl, (C1-C6)Haloalkyl, or (C3-C6) Cycloalkyl; or

[0558]R2And R7Together with the nitrogen atom to which they are attached to form a 6-membered or 7-membered heterocycloalkyl ring;

[0559]Each R3It is independently (C1-C6)Alkyl, (C1-C6)Alkoxy, (C1-C6)Haloalkyl, (C1-C6) Haloalkoxy, halogen, CN, -OH, or -NH2;or

[0560]Two R3Together with the carbon atoms to which they are attached (C3-C7) Cycloalkyl or 4- to 7-membered heterocycloalkyl ring, the heterocycloalkyl ring containing 1-3 heteroatoms selected from O, N and S; or when two R3When on adjacent carbon atoms together form a phenyl group, or a 5- or 6-membered heteroaryl ring, the heteroaryl ring contains 1-3 heteroatoms selected from O, N and S; or

[0561]R3And R7Together with the nitrogen and carbon atoms to which they are attached, a 5- or 6-membered heterocycloalkyl ring is formed, the heterocyc

Example Embodiment

[0579]Embodiment 3: The compound as described in embodiment 1 or 2, wherein R1Yes

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Binding affinityaaaaaaaaaa
Login to view more

Abstract

The present disclosure provides a compound of Formula (I'): (I') or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, wherein Ra, Rb, Rx, Ri, R2, X2, and q are as defined herein, methods of making and its use in the treatment of a disorder or disease associated with the reduction of IKZF2 protein levels.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner NOVARTIS AG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products